Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (11756)	10/20/2018 1:48:02 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 12215

First..... thank you! for A10..... "Transduced cells were detectable in peripheral blood at levels consistent with dose". for A4..... Transduced T-cells were detectable in the peripheral blood and expanded transiently, and greater persistence was related to higher T-cell dose Note that there is no mention of "transient" for A10. And the language for A4 indicates that cells were still observed after a transient expansion in their number??? So, if cells were observed in the periphery for A10 and their presence was continuous throughout monitoring, why would higher doses be expected to be more effective? Upsetting. I was not expecting a miracle, and have no position. Ugh.